Bryan M. Burt, MD, Santiago Ocejo, MD, Carlos M

Slides:

Advertisements

Similar presentations

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease Srikrishna Sirivella, MD, Isaac Gielchinsky,

Advertisements

What Predicts Long-Term Survival After Heart Transplantation

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma Giulio Melloni, MD, Claudio.

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection Bing-sheng Sun, MD, PhD, Yue.

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Operative Results and Outcomes in Children With Shone's Anomaly

Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer Servet Bölükbas,

Andrea S. Wolf, MD, MPH, Scott J

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Survival of Patients With or Without Symptoms Undergoing Potentially Curative Resections for Primary Lung Cancer Andrea R.G. Sheel, BS (Hons), MBChB,

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Samuel P. Morreau, David A. Haydock, MBChB, FRACS

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Primary Pulmonary Lymphoma

Andrea S. Wolf, MD, William G. Richards, PhD, Michael T

Who Do You Say You Are? The Annals of Thoracic Surgery

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Outcome of thoracoscopic pulmonary metastasectomy evaluated by confirmatory thoracotomy Eduard L Mutsaerts, MSc, Frans A Zoetmulder, MD, Sybren Meijer,

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Is Repeat Pulmonary Metastasectomy Indicated for Soft Tissue Sarcoma?

Anomalous Origin of Left Pulmonary Artery From Left Subclavian Artery

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Prolonged Overall Survival After Pulmonary Metastasectomy in Patients With Breast Cancer Georgios Meimarakis, MD, Dominik Rüttinger, MD, PhD, Joachim.

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

VATS Lobectomy Has Better Perioperative Outcomes Than Open Lobectomy: CALGB 31001, an Ancillary Analysis of CALGB (Alliance) Chukwumere E. Nwogu,

Outcomes After Transhiatal and Transthoracic Esophagectomy for Cancer

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Radiofrequency Ablation for the Treatment of Pulmonary Metastases

Extent of Lymphadenectomy Is Associated With Improved Overall Survival After Esophagectomy With or Without Induction Therapy Pamela Samson, MD, MPHS,

Characteristics of Malignant Pleural Mesothelioma in Women

Sequential thoracic metastasectomy prolongs survival by re-establishing local control within the chest Michael T. Jaklitsch, MDa, Carlos M. Mery, MDa,

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

A. Thomas Pezzella, MD, Sari D

Listing Low-Weight or Ill Infants for Heart Transplantation: Is It Prudent? Raheel Rizwan, MD, Farhan Zafar, MD, Clifford Chin, MD, James Tweddell, MD,

Modified T-Tube Repair of Delayed Esophageal Perforation Results in a Low Mortality Rate Similar to That Seen With Acute Perforations Philip A. Linden,

Attila Dubecz, MD, Thomas J. Watson, MD, Daniel P

Visceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size Elizabeth David, MD, Peter F. Thall, PhD,

Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer Shanda H. Blackmon, MD, MPH, Elizabeth.

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

Menopausal effects on presentation, treatment, and survival of women with non–small cell lung cancer Kimberly A Moore, MD, Carlos M Mery, MD, MPH, Michael.

Philip A. Linden, MD, Jon O. Wee, MD, Michael T

Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? Anna Lee, MD, MPH, Andrew T.

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Nabin K. Shrestha, MD, MPH, Jennifer Jue, MD, Syed T

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Prognostic Heterogeneity in Multilevel N2 Non-Small Cell Lung Cancer Patients: Importance of Lymphadenopathy and Occult Intrapulmonary Metastases Yukinori.

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural.

Modern Outcome and Risk Analysis of Surgically Resected Occult N2 Non-Small Cell Lung Cancer Hyun Jin Cho, MD, Sung Ryong Kim, MD, Hyeong Ryul Kim, MD,

Benny Weksler, MD, Manisha Shende, MD, Katie S

Relevance of Lymph Node Micrometastases in Radically Resected Endobronchial Carcinoid Tumors Tommaso Claudio Mineo, MD, Gianluca Guggino, MD, Davide.

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

Therapeutic R2 resection for pleural mesothelioma

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Presentation transcript:

Repeated and Aggressive Pulmonary Resections for Leiomyosarcoma Metastases Extends Survival Bryan M. Burt, MD, Santiago Ocejo, MD, Carlos M. Mery, MD, MPH, Marcelo Dasilva, MD, Raphael Bueno, MD, David J. Sugarbaker, MD, Michael T. Jaklitsch, MD The Annals of Thoracic Surgery Volume 92, Issue 4, Pages 1202-1207 (October 2011) DOI: 10.1016/j.athoracsur.2011.05.052 Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Kaplan-Meier survival plots of disease-free survival (A) and overall survival (B) in patients undergoing pulmonary metastasectomy for isolated leiomyosarcoma (LMS) and non-LMS pulmonary metastases. The Annals of Thoracic Surgery 2011 92, 1202-1207DOI: (10.1016/j.athoracsur.2011.05.052) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions